Economic evaluation of a psychological intervention for high distress cancer patients and carers: costs and quality-adjusted life years

Psycho-Oncology

Volumn , Issue , 2016, Pages 857-864

  Chatterton, Mary Lou ^a   Chambers, Suzanne ^b,c,d   Occhipinti, Stefano ^b   Girgis, Afaf ^e   Dunn, Jeffrey ^b,c,f   Carter, Rob ^a   Shih, Sophy ^a   Mihalopoulos, Cathrine ^a  

^a DEAKIN UNIVERSITY   (Australia)

^b GRIFFITH UNIVERSITY   (Australia)

^c CANCER COUNCIL QUEENSLAND   (Australia)

^d PROSTATE CANCER FOUNDATION OF AUSTRALIA   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BEHAVIOR THERAPY; BRIEF SYMPTOM INVENTORY; CANCER PATIENT; CAREGIVER; COMPARATIVE STUDY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISTRESS SYNDROME; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; NURSE LED MINIMAL CONTACT SELF MANAGEMENT; PERSONALIZED MEDICINE; PROBABILITY; PSYCHOLOGIST LED INDIVIDUALISED COGNITIVE BEHAVIORAL INTERVENTION; PSYCHOTHERAPY; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SELF CARE; SENSITIVITY ANALYSIS; TELEPHONE INTERVIEW; UNCERTAINTY;

EID: 84977676220     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.4020     Document Type: Article

References (29)

1. Institute for Health Metrics and Evaluation. Global Burden of Disease 2013. Accessed 13 March 2013 (Available from: http://www.healthmetricsandevaluation.org/gbd.)
2. Andrykowski MA, Cordova MJ, McGrath PC, Sloan DA, Kenady DE. Stability and change in posttraumatic stress disorder symptoms following breast cancer treatment: a 1-year follow-up. Psycho-Oncology 2000;9(1):69–78.
3. Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S. The prevalence of psychological distress by cancer site. Psycho-Oncology 2001;10(1):19–28.
4. Chambers SK, Schover L, Nielsen L, et al. Couple distress after localised prostate cancer. Support Care Cancer 2013. DOI:10.1007/s00520-013-1868-6.
5. Turner J, Zapart S, Pedersen K, Rankin N, Luxford K, Fletcher J. Clinical practice guidelines for the psychosocial care of adults with cancer. Psycho-Oncology 2005;14(3):159–173.
6. Gordon LG, Beesley VL, Scuffham PA. Evidence on the economic value of psychosocial interventions to alleviate anxiety and depression among cancer survivors: a systematic review. Asia Pac J Clin Oncol 2011;7(2):96–105. DOI:10.1111/j.1743-7563.2011.01395.x.
7. Chambers SK, Girgis A, Occhipinti S, et al. Beating the blues after cancer: randomised controlled trial of a tele-based psychological intervention for high distress patients and carers. BMC Cancer 2009;9:189. DOI:10.1188/14.ONF.E256-E266.
8. National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology: Distress Management [v2.2014] 2014. Accessed 2014 11 August 2014 (Available from: http://www.nccn.org/professionals/physician_gls/pdf/distress.pdf.)
9. Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC. Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 1998;82(10):1904–1908.
10. Chambers SK, Girgis A, Occhipinti S, et al. A randomized trial comparing two low-intensity psychological interventions for distressed patients with cancer and their caregivers. Oncol Nurs Forum 2014;41(4):E256–E266.
11. Drummond M, Sculpher MJ, Torrance GW, O'Brien BJ, Stoddart GL. Methods for the Economic Evaluation of Health Care Programmes (3rd ed.), Oxford University Press: Oxford, 2005.
12. Glick H, Doshi JA, Sonnad SS, Polsky D. Economic Evaluation in Clinical Trials, Oxford University Press: Oxford; New York, 2007.
13. Carter R, Vos T, Moodie M, et al. Priority setting in health: origins, description and application of the Australian assessing cost-effectiveness (ACE) initiative. Expert Rev Pharmacoecon Outcomes Res 2008;8(6):593–617.
14. Australian Government, Department of Human Services. Medicare item reports. Accessed 27 August 2014 (Available from: https://www.medicareaustralia.gov.au/statistics/mbs_item.shtml.)
15. Australian Government, Department of Human Services. Pharmaceutical benefits schedule item reports. Accessed 27 August 2014 (Available from: https://www.medicareaustralia.gov.au/statistics/pbs_item.shtml.)
16. Richardson J, Iezzi A, Khan MA, Maxwell A. Validity and reliability of the assessment of quality of life (AQoL)-8D multi-attribute utility instrument. The Patient 2014;7(1):85–96. DOI:10.1007/s40271-013-0036-x.
17. Mihalopoulos C, Chen G, Iezzi A, Khan MA, Richardson J. Assessing outcomes for cost-utility analysis in depression: comparison of five multi-attribute utility instruments with two depression-specific outcome measures. Br J Psychiatry 2014;205(5):390–397.
18. Centre for Health Economics. AQoL-8D utility algorithms. Accessed 27 August 2014 (Available from: http://www.aqol.com.au/index.php/scoring-algorithms.)
19. Rubin DB. Multiple Imputation for Nonresponse in Surveys. Wiley Series in Probability and Mathematical Statistics. Applied Probability and Statistics, Wiley: New York, xxix, 1987;258.
20. Rutten-van Mölken MP, van Nooten FE, Lindemann M, Caeser M, Calverley PM. A 1-year prospective cost-effectiveness analysis of roflumilast for the treatment of patients with severe chronic obstructive pulmonary disease. Pharmacoeconomics 2007;25(8):695–711.
21. Richardson J, Khan MA, Chen G, Iezzi A, Maxwelll A. Population Norms and Australian Profile using the Assessment of Quality of Life (AQoL) 8D Utility Instrument. Research Paper 2012 (72), Monash University, Centre for Health Economics. Available at: http://www.aqol.com.au/documents/AQoL-8D/researchpaper72.pdf. Accessed 28 October 2015.
22. Chambers SK, Girgis A, Occhipinti S, et al. Intervening to improve psychological outcomes after cancer: what is known and where next? Aust Psychol 2014;49(2):96–103. DOI:10.1111/j.1365-2354.2011.01288.x.
23. Chambers SK, Girgis A, Occhipinti S, et al. Psychological distress and unmet supportive care needs in cancer patients and carers who contact cancer helplines. Eur J Cancer Care 2012;21(2):213–223. DOI:10.1111/j.1365-2354.2011.01288.x.
24. Australian Institute of Health and Welfare, Australasian Association of Cancer Registries. Cancer in Australia: An Overview, AIHW: Caberra, 2012.
25. Walker S, Walker J, Richardson G, et al. Cost-effectiveness of combining systematic identification and treatment of co-morbid major depression for people with chronic diseases: the example of cancer. Psychol Med 2014;44(07):1451–1460. DOI:10.1017/S0033291713002079.
26. Holland J, Watson M, Dunn J. The IPOS new International Standard of Quality Cancer Care: integrating the psychosocial domain into routine care. Psycho-Oncology 2011;20(7):677–680. DOI:10.1002/pon.1978.
27. Donovan KA, Grassi L, McGinty HL, Jacobsen PB. Validation of the distress thermometer worldwide: state of the science. Psycho-Oncology 2014;23(3):241–250. DOI:10.1002/pon.3430.
28. Chambers SK, Zajdlewicz L, Youlden DR, Holland JC, Dunn J. The validity of the distress thermometer in prostate cancer populations. Psycho-Oncology 2014;23(2):195–203. DOI:10.1002/pon.3391.
29. Hutchison SD, Steginga SK, Dunn J. The tiered model of psychosocial intervention in cancer: a community based approach. Psycho-Oncology 2006;15(6):541–546. DOI:10.1002/pon.973.